|
Characteristic
|
Omeprazole group (n = 303)
|
Pantoprazole group (n = 304)
|
P value
|
|---|
|
Stent thrombosis [n (%)]
|
0
|
1 (0.3)
|
1.00
|
|
MACEs [n (%)]
|
7 (2.3)
|
5 (1.6)
|
0.58
|
|
Cardiac death
|
1 (0.3)
|
0
|
0.50
|
|
Myocardial infarction
|
0
|
0
|
—
|
|
Ischemic symptoms driven target vessel revascularization
|
1 (0.3)
|
0
|
0.50
|
|
Non-target vessel revascularization
|
5 (1.7)
|
5 (1.6)
|
1.00
|
|
Recurrent angina [n (%)]
|
19 (6.3)
|
12 (3.9)
|
0.20
|
|
All-cause death [n (%)]
|
1 (0.3)a
|
0
|
0.50
|
|
TIMI bleeding events [n (%)]
|
|
Major
|
0
|
0
|
—
|
|
Moderate
|
0
|
0
|
—
|
|
Minor
|
4 (1.3)
|
8 (2.6)
|
0.38
|
|
Stroke [n (%)]
|
0
|
0
|
—
|
|
Adverse drug reactions [n (%)]
|
23 (7.6)
|
29 (9.5)
|
0.47
|
|
AEs [n (%)]
|
46 (15.2)
|
45 (14.8)
|
0.91
|
-
aOne patient died due to brain injury in the omeprazole group
